About
Pharmaceuticals
KinBio is wholly-owned local subsidiary of Hong Kong-based pharmaceutical and food retailer Gencor Pacific which had acquired the assets of Israel-based pharmaceutical company InSight. KinBio is developing a large portfolio of technologies for manufacturing generic versions of complex drugs, high-quality biosimilars and biologics. The company is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoporosis. .
Identity
| Name | KinBio |
|---|---|
| Slug | kinbio |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JOU9ZcJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jan 2025 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country | Hong Kong |
|---|---|
| HQ country code | HK |
| HQ region/district | Center District |
| HQ address | Hong Kong |
Web & social
| https://www.linkedin.com/company/18997598 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Business models
B2B
Tags
pharmaceuticalsoncology
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}